Autor(es)

Franco, Yollanda E. M. ; de Lima, Carolina A. ; Rosa, Marcela N. ; Silva, Viviane A. O. ; Reis, Rui M. ; Priolli, Denise G. ; Carvalho, Patricia O. ; do Nascimento, Jessyane R. ; da Rocha, Claudia Q. ; Longato, Giovanna B.

• Tipo de documento: Artigo Científico
• Fonte: NATURAL PRODUCT RESEARCH; v. 35, n. 22, p. 7-pg., 2020-02-20.

Resumo

Recently, many studies have reported the anticancer properties of flavonoid luteolin against a variety of tumors, but there is still a lack in the description of its mechanism of action. In attempt to better contribute to the literature, we evaluated the antiproliferative activity of luteolin extracted by Fridericia platyphylla in a panel of tumor cell lines representative of six different tissues. Luteolin presented antiproliferative activity for all the assessed tumor cell lines, being glioblastoma the most sensitive one. This compound was able to inhibit U-251 cells migration and tumorigenesis. Besides, luteolin leads U-251 tumor cells to apoptosis death by depolarisation of the mitochondrial membrane, ERK proteins phosphorylation, cleavage of PARP and Caspase 9, further inducing DNA damage by H2AX phosphorylation, which had not yet been described for glioblastomas. Altogether, our results reaffirm luteolin as a potential therapeutic drug. (AU)

• Processo FAPESP: 16/06137-6 - Bioprospecção de compostos naturais e derivados bioativos com potencial atividade anticâncer: ensaios in vitro/in vivo e investigação do mecanismo de ação.
• Beneficiário: Giovanna Barbarini Longato
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 16/02345-3 - Estudo in vitro e in vivo da atividade anticâncer de flavonoides e flavonoides biomodificados
• Beneficiário: Yollanda Edwirges Moreira Franco
• Modalidade de apoio: Bolsas no Brasil - Mestrado